✨ Your Portfolio is fetched and updated from zerodha.

Natco Pharma Ltd.

NATCOPHARM

Market Cap
₹25,130 Cr.
P/E
15.36

Natco Pharma Ltd.

  • Natco Pharma
  • Orchid Pharma
  • Jubilant Pharmova
  • TJI Pharma
FAQs on Natco Pharma Ltd. Shareprice

Natco Pharma has given lower returns compared to its competitors.
Natco Pharma has grown at ~14.29% over the last 3yrs while peers have grown at a median rate of 20.92%

Natco Pharma is not expensive.
Latest PE of Natco Pharma is 14.91, while 3 year average PE is 31.99.
Also latest EV/EBITDA of Natco Pharma is 11.74 while 3yr average is 24.17.

View FAQ's On Business
Growth Table
  • Natco Pharma Ltd.
  • Orchid Pharma
  • Jubilant Pharmova
Balance Sheet
  • Natco Pharma Ltd.
  • Orchid Pharma
  • Jubilant Pharmova
Balance Sheet Snapshot
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
*Data is as of latest FY end
Profit & Loss
  • Natco Pharma Ltd.
  • Orchid Pharma
  • Jubilant Pharmova
Cash Flow
  • Natco Pharma Ltd.
  • Orchid Pharma
  • Jubilant Pharmova
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
Ratios
= Dominant Factor
  • Natco Pharma Ltd.
  • Orchid Pharma
  • Jubilant Pharmova
Quarterly Results
  • Natco Pharma Ltd.
  • Orchid Pharma
  • Jubilant Pharmova
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Natco Pharma Ltd. Financials

Balance sheet of Natco Pharma is strong.
It shouldn't have solvency or liquidity issues.

The debt of Natco Pharma is decreasing.
Latest debt of Natco Pharma is -₹1,542.3 Crs as of Mar-24.
This is less than Mar-23 when it was -₹927.3 Crs.

Yes, profit is increasing.
The profit of Natco Pharma is ₹1,636 Crs for TTM, ₹1,388 Crs for Mar 2024 and ₹715 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Natco Pharma latest dividend payout ratio is 12.25% and 3yr average dividend payout ratio is 24.86%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
timeline Timeline
watchlist Watchlist
portfolio Portfolio
alerts Alerts
filter Research
filter Stock Screener
markets Market
raw materials Raw Material
Data feed provided by Accord Fintech